CREFX | REACX | CREFX / REACX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 8 years | 29 years | - |
Gain YTD | 0.811 | 0.114 | 710% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.66B | 692M | 1,107% |
Annual Yield % from dividends | 3.03 | 2.28 | 133% |
Returns for 1 year | 11.50 | 12.45 | 92% |
Returns for 3 years | -7.99 | -11.28 | 71% |
Returns for 5 years | 11.90 | -6.26 | -190% |
Returns for 10 years | N/A | -1.50 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NDVIX | 18.64 | 0.09 | +0.49% |
MFS New Discovery Value I | |||
BRKTX | 13.74 | 0.06 | +0.44% |
MFS Blended Research Em Mkts Eq R3 | |||
TRAIX | 35.24 | 0.13 | +0.37% |
T. Rowe Price Capital Appreciation I | |||
AWYIX | 59.89 | 0.01 | +0.02% |
CIBC Atlas Equity Income Institutional | |||
CPLSX | 16.21 | -0.09 | -0.55% |
Calamos Phineus Long/Short A |